ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Ovarian cancer (OC) presents significant treatment challenges, particularly in late stages.
• MicroRNA (miRNA) dysregulation and reactive oxygen species (ROS) are implicated in OC development and progression.
• Signaling pathways like PI3K/AKT and MAPK are activated by ROS, contributing to tumorigenesis.

Purpose of the Study:

• To review the roles of specific miRNAs, NOX4, and ROS in ovarian cancer.
• To elucidate their contribution to therapeutic resistance in OC.
• To highlight potential therapeutic strategies targeting these mechanisms.

Main Methods:

• Literature review of current research on miRNAs, NOX4, and ROS in OC.
• Analysis of molecular mechanisms underlying OC progression and therapeutic resistance.
• Discussion of angiogenic factors like HIF-1 and VEGF in OC.

Main Results:

• miRNAs and ROS significantly influence OC tumorigenesis and angiogenesis.
• NOX4 is a key mediator of ROS production in OC.
• These factors contribute to therapeutic resistance in ovarian cancer.

Conclusions:

• Targeting specific miRNAs and ROS pathways, including NOX4, shows promise for overcoming OC therapeutic resistance.
• Further research into these mechanisms could yield effective new treatments for ovarian cancer.
• Understanding miRNA and ROS interplay is crucial for advancing OC therapy.